CervoMed Inc. (CRVO)

CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.74	7.79	4.09	6.67
Cash & Short-Term Investments	46.66	7.79	4.09	6.67
Cash Growth	347.56%	90.37%	-38.59%	-
Accounts Receivable	0.26	0.92	-	-
Other Receivables	-	-	-	0.07
Receivables	0.26	0.92	-	0.07
Prepaid Expenses	1.89	1.26	0.06	0.02
Other Current Assets	-	-	-	0.05
Total Current Assets	48.81	9.96	4.16	6.82
Other Long-Term Assets	0.07	0.01	-	-
Total Assets	48.88	9.97	4.16	6.82
Accounts Payable	1.08	0.66	0.1	0.02
Accrued Expenses	2.07	1.84	0.59	0.4
Current Portion of Long-Term Debt	-	-	12.41	4.11
Other Current Liabilities	0.1	0.09	0.05	0.03
Total Current Liabilities	3.25	2.6	13.16	4.56
Long-Term Debt	-	-	-	5.92
Total Liabilities	3.25	2.6	13.16	10.47
Common Stock	0.01	0.01	0	0
Additional Paid-In Capital	109.53	61.81	18.98	18.52
Retained Earnings	-64.03	-54.44	-52.27	-46.47
Total Common Equity	45.64	7.38	-33.29	-27.94
Shareholders' Equity	45.64	7.38	-9	-3.66
Total Liabilities & Equity	48.88	9.97	4.16	6.82
Total Debt	-	-	12.41	10.03
Net Cash (Debt)	46.66	7.79	-8.32	-3.36
Net Cash Per Share	6.25	2.93	-16.06	-0.75
Filing Date Shares Outstanding	8.25	6.17	4.5	4.5
Total Common Shares Outstanding	8.25	5.67	4.5	4.5
Working Capital	45.56	7.37	-9	2.26
Book Value Per Share	5.53	1.30	-7.39	-6.21
Tangible Book Value	45.64	7.38	-33.29	-27.94
Tangible Book Value Per Share	5.53	1.30	-7.39	-6.21

Source: S&P Capital IQ. Standard template. Financial Sources.